Federica Mazzuca

1.5k total citations
53 papers, 960 citations indexed

About

Federica Mazzuca is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Federica Mazzuca has authored 53 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Federica Mazzuca's work include Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Federica Mazzuca is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Federica Mazzuca collaborates with scholars based in Italy, United States and United Kingdom. Federica Mazzuca's co-authors include Paolo Marchetti, Andrea Botticelli, Michela Roberto, Maurizio Simmaco, Ilaria Grazia Zizzari, Bruna Cerbelli, Luana Lionetto, Marianna Nuti, Concetta Elisa Onesti and Lidia Strigari and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Federica Mazzuca

52 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federica Mazzuca Italy 17 585 231 218 125 89 53 960
Van Vuong United States 15 420 0.7× 182 0.8× 287 1.3× 242 1.9× 59 0.7× 45 1.0k
Matthias Unseld Austria 18 407 0.7× 163 0.7× 267 1.2× 89 0.7× 110 1.2× 80 1.0k
Barbara Melotti Italy 17 502 0.9× 263 1.1× 182 0.8× 62 0.5× 63 0.7× 69 826
Loredana Santo United States 16 582 1.0× 155 0.7× 510 2.3× 103 0.8× 57 0.6× 39 1.2k
Sarah Waliany United States 14 445 0.8× 177 0.8× 169 0.8× 90 0.7× 41 0.5× 34 857
Feng Xiao China 19 275 0.5× 127 0.5× 151 0.7× 81 0.6× 81 0.9× 58 858
Sandra A. Radema Netherlands 17 505 0.9× 149 0.6× 244 1.1× 160 1.3× 290 3.3× 37 1.1k
Nora Sundahl Belgium 16 321 0.5× 275 1.2× 161 0.7× 111 0.9× 213 2.4× 39 863

Countries citing papers authored by Federica Mazzuca

Since Specialization
Citations

This map shows the geographic impact of Federica Mazzuca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Mazzuca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Mazzuca more than expected).

Fields of papers citing papers by Federica Mazzuca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Mazzuca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Mazzuca. The network helps show where Federica Mazzuca may publish in the future.

Co-authorship network of co-authors of Federica Mazzuca

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Mazzuca. A scholar is included among the top collaborators of Federica Mazzuca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Mazzuca. Federica Mazzuca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pilozzi, Emanuela, Maria Rinzivillo, Damiano Caruso, et al.. (2024). Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case Presentation. Biomedicines. 12(2). 379–379. 2 indexed citations
3.
Mazzuca, Federica, et al.. (2024). Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy applications in upper and lower gastrointestinal cancer, a review. Oncology Reviews. 18. 1496141–1496141. 1 indexed citations
4.
Roberto, Michela, Giacomo Barchiesi, Emanuela Pilozzi, et al.. (2023). The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets. Frontiers in Oncology. 13. 1154581–1154581. 12 indexed citations
5.
Milano, Annalisa, et al.. (2022). Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach. Radiology and Oncology. 56(3). 285–291. 14 indexed citations
6.
Krokidis, Μiltiadis, Marta Zerunian, Tiziano Polidori, et al.. (2021). Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features. Diagnostics. 11(6). 956–956. 12 indexed citations
7.
Rinzivillo, Maria, Daniela Prosperi, Federica Mazzuca, et al.. (2020). 1185P [18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia. Annals of Oncology. 31. S782–S782. 1 indexed citations
8.
Roberto, Michela, Adriana Romiti, Federica Mazzuca, et al.. (2020). Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial. Cancers. 12(11). 3084–3084. 5 indexed citations
9.
Rinzivillo, Maria, Daniela Prosperi, Federica Mazzuca, et al.. (2020). [18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia. Journal of Endocrinological Investigation. 44(4). 811–818. 2 indexed citations
10.
Mazzuca, Federica, Maria Rinzivillo, Emanuela Pilozzi, et al.. (2019). Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center. Journal of Clinical Medicine. 8(6). 910–910. 32 indexed citations
11.
Botticelli, Andrea, Massimiliano Salati, Francesca Romana Di Pietro, et al.. (2019). A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab. Journal of Translational Medicine. 17(1). 99–99. 43 indexed citations
12.
13.
Botticelli, Andrea, Bruna Cerbelli, Luana Lionetto, et al.. (2018). Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?. Journal of Translational Medicine. 16(1). 219–219. 98 indexed citations
14.
Mazzuca, Federica, Concetta Elisa Onesti, Michela Roberto, et al.. (2018). Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines. Oncotarget. 9(39). 25714–25722. 46 indexed citations
15.
Cerbelli, Bruna, Angelina Pernazza, Andrea Botticelli, et al.. (2017). PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?. BioMed Research International. 2017. 1–7. 48 indexed citations
16.
Occhipinti, Margherita, Andrea Botticelli, Concetta Elisa Onesti, et al.. (2017). Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres. Annals of Oncology. 28. vi50–vi50. 1 indexed citations
17.
Botticelli, Andrea, Bruna Cerbelli, Angelina Pernazza, et al.. (2017). PD-L1 expression in TNBC: A predictive biomarker of response to neoadjuvant chemotherapy?. Annals of Oncology. 28. v30–v30. 1 indexed citations
18.
Botticelli, Andrea, Marina Borro, Concetta Elisa Onesti, et al.. (2016). Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?. PLoS ONE. 11(9). e0163105–e0163105. 10 indexed citations
19.
Onesti, Concetta Elisa, Andrea Botticelli, Marco La Torre, et al.. (2016). 5-Fluorouracil degradation rate could predict toxicity in stages II–III colorectal cancer patients undergoing adjuvant FOLFOX. Anti-Cancer Drugs. 28(3). 322–326. 9 indexed citations
20.
Gentile, Giovanna, Andrea Botticelli, Luana Lionetto, et al.. (2015). Genotype–phenotype correlations in 5-fluorouracil metabolism: a candidate DPYD haplotype to improve toxicity prediction. The Pharmacogenomics Journal. 16(4). 320–325. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026